AtriCure (ATRC) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $59.12 +3.47%
Revenue Growth %: +12.6%
Financial Fact:
Total operating expenses: 33.76M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: +12.6%
Financial Fact:
Total operating expenses: 33.76M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.30), $0.01 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $73.2 million versus the consensus estimate of $72.39 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Halozyme prices $1.3B convertible notes offering due 2033
- Empress Royalty acquires Tongon gold stream for $62M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
